(Q48620601)

English

Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype

scientific article published on December 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype (English)

reason for preferred rank

most precise value

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1686301

29 October 2022

0 references

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

author name string

A. F. Arnsten

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1686301

29 October 2022

F. M. Leslie

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1686301

29 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1686301

29 October 2022

publication date

1 December 1991

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

full work available at URL

https://api.elsevier.com/content/article/PII:0028390891900246?httpAccept=text/xml

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

https://api.elsevier.com/content/article/PII:0028390891900246?httpAccept=text/plain

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Neuropharmacology

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

30

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

1279-1289

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

12A

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

1

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates.

2

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Aging in the Rhesus Monkey: Debilitating Effects on Short-term Memory

3

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain

6

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Heterogeneity of alpha-2 adrenergic receptors

7

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

8

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Clonidine ameliorates Gilles de la Tourette syndrome

9

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Clinical pharmacology and pharmacokinetics of clonidine

10

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

A procedure for measuring alpha 2-adrenergic receptor-mediated inhibition of cyclic AMP accumulation in rat brain slices.

11

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla

12

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings.

13

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Clonidine reverses the amnesia induced by dopamine beta hydroxylase inhibition

14

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey.

15

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys

16

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex

17

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.

18

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

19

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor

20

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Inhibition of cyclic AMP accumulation by alpha 2-adrenoceptors in the rat cerebral cortex.

21

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Presynaptic regulation of catecholamine release

22

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Korsakoff's psychosis: Noradrenergic systems and cognitive impairment

26

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Evidence for task-dependent memory dysfunction in the aged monkey

29

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.

32

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Identification of α2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells

33

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension

34

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Characterization of .alpha.-adrenoceptor populations. Quantitative relationships between cardiovascular effects initiated at central and peripheral .alpha.-adrenoceptors

35

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Guanabenz, guanochlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes

37

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

The neural basis of memory decline in aged monkeys

38

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Alpha 2-adrenergic receptors mediate inhibition of cyclic AMP production in neurons in primary culture

39

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?

42

1 reference

10.1016/0028-3908(91)90024-6

https://api.crossref.org/works/10.1016/0028-3908(91)90024-6

29 October 2022

Identifiers

10.1016/0028-3908(91)90024-6

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/1686301

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48620601&oldid=1760323946"